Satellos Bioscience Announces 2023 Year End Financial Results and Operational Highlights
– Engaged CRO for first-in-human SAT-3247 Phase 1 clinical study – Initiated GLP toxicity studies and GMP manufacturing of SAT-3247 – Continues... Read more.
METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
The METIS trial demonstrated 21.9 months median time to intracranial progression for patients treated with Tumor Treating Fields and supportive care compared to... Read more.
Southland Awarded $56 million Wastewater Treatment Plant Facility Project
GRAPEVINE, Texas–(BUSINESS WIRE)–Southland Holdings, Inc. (NYSE American: SLND and SLND WS) (“Southland”) announced today that a subsidiary in its... Read more.
Visa’s Growing Services Business Infused with New AI-Powered Products
Three new AI-powered solutions are added to Visa Protect suite to help block fraud Among the newest services: a cutting-edge immediate payment fraud solution and... Read more.
BearingPoint Elects Stefan Penthin to Be the Next Managing Partner of the Global Firm
Kiumars Hamidian will hand over to Stefan Penthin on September 1, 2024, as part of a planned process after two terms in office AMSTERDAM–(BUSINESS WIRE)–#advisory–With,... Read more.
AV Pro Global Appoints Chief Operating Officer
Veteran Executive Joins AV Distribution Leader to Further Enterprise Success SIOUX FALLS, S.D.–(BUSINESS WIRE)–AVPro Global Holdings, LLC, parent company... Read more.
Kimco Realty® Announces First Quarter Transaction Activity Highlighted by the Sale of Ten Former RPT Properties for $248 Million
– Achieves 2024 RPT Disposition Target Ahead of Schedule – – New Investment Activity Expected to Outpace Dispositions for Remainder of 2024 – JERICHO, N.Y.–(BUSINESS... Read more.
Spire Global Announces Space Services Deal to Scale Constellation for HANCOM InSpace
Sejong-2 and Sejong-3 will complement Sejong-1 to expand image analysis solutions VIENNA, Va.–(BUSINESS WIRE)–Spire Global, Inc. (NYSE: SPIR) (“Spire”... Read more.
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
– Initiated final IND/CTA enabling studies for lead in vivo gene editing program PBGENE-HBV; expect to submit IND and/or CTA in 2024 – Completed licensing... Read more.
QuantumScape Begins Customer Shipments of Alpha-2 Prototypes, a Key Goal for 2024
SAN JOSE, Calif.–(BUSINESS WIRE)–QuantumScape Corporation (NYSE: QS), a leader in next-generation solid-state lithium-metal battery technology, today... Read more.